News for Navidea Biopharmaceuticals, Inc. (NAVB)

Navidea Biopharmaceuticals, Inc. (OTC: NAVB) extends the authority to implement a reverse stock split until July 8, 2027. The reverse stock split ratio

Navidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024

TGH | Complete Textainer Group Holdings Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Navidea Biopharmaceuticals, Inc. dropped from S&P TMI Index...

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday.

Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of $0.10/less for 10 consecutive trading days.

Following the Company’s Fix, Fund, Propel approach, Navidea continues forward-focus to advance innovative technology to market while intending to appeal the potential delisting of its stock from...

Navidea Biopharma Announces NYSE American Has Commenced Delisting Proceedings

Navidea Biopharmaceuticals, Inc. , a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, received written notification from NYSE American LLC stating...

Navidea Biopharma Announces Board Changes

In line with the Company’s Fix, Fund, Propel approach, Dana J Moss, JD joins Navidea’s Board, adding depth in legal advice, strategic business, life sciences and technology in support of stated strategy to advance innovative technology to market. Separately, Amit Bhalla steps down from Board.

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 9) Abbott ...